Today on THCB Spotlights, Matthew speaks with Jeremy Orr, CEO of Medial EarlySign. Medial EarlySign does complex algorithmic detection of elevated risk trajectories for high-burden serious diseases, and the progression towards chronic diseases such as diabetes.
EarlySign (, a leader in machine learning-based solutions to aid in the early detection and prevention of high-burden diseases, today announced the appointment of Jeremy Orr, MD, MPH, as its new Chief Executive Officer.

Are you looking to solve high-burden disease challenges?